Skip to main content

Table 1 Demographic and clinical characteristics between ALI and non-ALI patients

From: Plasma level of advanced oxidation protein products as a novel biomarker of acute lung injury following cardiac surgery

 

ALL (n = 70)

ALI (n = 18)

Non-ALI (n = 52)

P value

Basic parameters

 Male (n)

37

12

25

<0.001

 Age (years)

47.9 ± 11.3

57.7 ± 11.6

46.6 ± 11.4

0.105

 Body mass index

21.6 ± 3.60

22.9 ± 2.90

21.1 ± 3.8

0.081

 Smoking (n)

15

6

9

0.153

 COPD (n)

7

5

2

0.01

 Hypertension (n)

9

6

3

0.007

 Diabetes mellitus (n)

4

3

1

0.05

 Cardiothoracic ratio

0.61 ± 0.09

0.63 ± 0.08

0.61 ± 0.1

0.415

 LVEF(%)

59.9 ± 7.0

57.9 ± 6.5

60.6 ± 7.1

0.154

Intraoperative parameters

 Type of surgery

   

0.223

  Coronary artery disease (%)

11 (15.7 %)

5 (27.8 %)

6 (11.5 %)

 

  Valve heart disease (%)

52 (74.3 %)

12 (66.7 %)

40 (77.0 %)

 

  Congenital heart disease (%)

7 (10 %)

1 (5.5 %)

6 (11.5 %)

 

 CPB time (min)

106.4 ± 37.8

116.3 ± 31.5

102.9 ± 39.4

0.198

 Clamp time (min)

68.5 ± 30.8

73.3 ± 24

66.9 ± 32.9

0.452

Peri-operative risk factors

 Preoperative AOPPs (μmol/L)

46.0 ± 10.5

47.1 ± 7.9

44.8 ± 10.8

0.394

 SICU stay (days)

3 (2, 5)

7.3 ± 4.4

3 (2, 3)

<0.001

 Hospital stay (days)

17.3 ± 5.9

24.4 ± 5.8

14.8 ± 3.4

<0.001

  1. Data are presented as number of patients (%), mean ± SD, or counts, as appropriate
  2. ALI acute lung injury, COPD chronic obstructive pulmonary disease, LVEF left ventricular ejection fraction, CPB cardiopulmonary bypass, SICU surgery intensive care unit